Nesh Pharmatech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 14.20%
- Ebitda -4.89%
- Net Worth -4.20%
- Total Assets -0.36%
About Nesh Pharmatech
Nesh Pharmatech Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 May 2009 and has a history of 15 years and eight months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nitika Kala and Priyanka Misra serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U73100MH2009PTC192701
- Company No.
192701
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 May 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Nesh Pharmatech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitika Kala  | Director | 31-Mar-2016 | Current |
| Priyanka Misra | Director | 12-Apr-2016 | Current |
Financial Performance of Nesh Pharmatech.
Nesh Pharmatech Private Limited, for the financial year ended 2015, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 14.2% increase in profit. The company's net worth dipped by a decrease of 4.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nesh Pharmatech?
In 2017, Nesh Pharmatech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Revon Consultancy & Management Services Private LimitedNitika Kala is a mutual person
- Emeca Consultancy Services Private Limited
Nitika Kala is a mutual person
- Venus Global Management & Consultancy Services Private Limited
Nitika Kala is a mutual person
- Futuristic Ventures Private Limited
Priyanka Misra is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nesh Pharmatech?
Unlock and access historical data on people associated with Nesh Pharmatech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nesh Pharmatech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nesh Pharmatech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
